Several years ago, we reviewed a paper suggesting that estrogen may have beneficial effects for women with schizophrenia. In this study, women with schizophrenia were treated with estrogen in addition to their antipsychotic medications. Adjunctive [...]
Perimenopausal vasomotor symptoms are triggered by a fall in circulating levels of estrogen and other sex steroids. It has been hypothesized that thermoregulatory centres in the hypothalamus play a crucial role in mediating the hot [...]
Over the years there have been multiple reports indicating that women with schizophrenia may experience worsening of their symptoms as they transition into the menopause. In addition, while schizophrenia typically has its onset in young [...]
Estrogens have neuroprotective and antidepressant effects. During the perimenopause, when estrogen levels fluctuate and then fall significantly, women are more vulnerable to depression and cognitive deficits. A recent study has investigated the association between age [...]
Several recent articles indicate that the burden of menopausal symptoms is greater than generally perceived. About 80% of women experience vasomotor symptoms (VMS) – hot flashes and night sweats — as they transition into the [...]
A recent paper from the European Menopause and Andropause Society (EMAS) reviews non-hormonal therapy options for the treatment of menopausal vasomotor symptoms. This EMAS position paper provides guidance for treaters managing peri- and postmenopausal women [...]
A recent study of 2507 menopausal women suggests that menopausal women with higher caffeine intake are more likely to have hot flashes and night sweats; however, they have fewer problems with mood, memory, and concentration. [...]
About 70% of perimenopausal women experience vasomotor symptoms, including hot flashes. A new study indicates that a behavioral program focusing on weight loss may help to reduce the severity and frequency of hot flashes.
Previous studies have shown that the abrupt hormonal changes that occur after a surgical menopause (i.e., removal of the ovaries) negatively affect cognition in women. According to a recent study, "Women who were younger at the time of surgical menopause have a more rapid rate (steeper slope) of cognitive decline than women who were older at the time of surgery or than women undergoing natural menopause." Earlier age at menopause was also associated with increased Alzheimer’s disease neuropathology, in particular neuritic plaques.